Myocardial infarction during follow-up | All-cause mortality | |||||
---|---|---|---|---|---|---|
No | Yes | p | No | Yes | p | |
N | 3042 | 95 | 2554 | 438 | ||
Male sex (%) | 73.0 | 75.8 | 0.54 | 72.2 | 77.2 | 0.03 |
Age (years) | 65.6 ± 8.3 | 65.9 ± 8.8 | 0.79 | 64.8 ± 8.1 | 70.5 ± 8.5 | <0.0001 |
Duration of diabetes (years) | 10.4 ± 7.7 | 11.3 ± 8.6 | 0.49 | 10.1 ± 7.6 | 12.3 ± 8.2 | <0.0001 |
Body mass index (kg/m2) | 29.4 ± 4.6 | 29.1 ± 4.2 | 0.60 | 29.5 ± 4.6 | 28.8 ± 4.9 | 0.0008 |
Systolic blood pressure (mmHg) | 144 ± 13 | 146 ± 16 | 0.14 | 144 ± 13 | 146 ± 13 | 0.007 |
Diastolic blood pressure (mmHg) | 82 ± 8 | 81 ± 8 | 0.29 | 82 ± 8 | 82 ± 8 | 0.99 |
HbA1c (%) and (mmol/mol) | 7.9 ± 1.8 (62 ± 19) | 8.2 ± 1.8 (66 ± 20) | 0.06 | 7.8 ± 1.7 (62 ± 19) | 8.0 ± 2.0 (64 ± 22) | 0.35 |
Urinary albumin excretion (mg/l) | 76 (144) | 78 (162) | 0.92 | 72 (130) | 109 (278) | <0.0001 |
eGFR (ml/min) | 78 ± 22 | 75 ± 20 | 0.14 | 78 ± 22 | 72 ± 21 | <0.0001 |
Total cholesterol (mmol/l) | 5.79 ± 1.07 | 6.00 ± 1.25 | 0.18 | 5.78 ± 1.05 | 5.84 ± 1.15 | 0.37 |
HDL- cholesterol (mmol/l) | 1.32 ± 0.36 | 1.25 ± 0.26 | 0.15 | 1.32 ± 0.35 | 1.29 ± 0.34 | 0.17 |
LDL- cholesterol (mmol/l) | 3.52 ± 0.88 | 3.72 ± 1.02 | 0.10 | 3.53 ± 0.87 | 3.51 ± 0.92 | 0.61 |
Triglycerides (mmol/l) | 1.83 (1.36) | 1.81 (1.77) | 0.53 | 1.84 (1.32) | 1.84 (1.49) | 0.69 |
Lipids lowering therapy (%) | 35.5 | 33.7 | 0.71 | 36.0 | 32.2 | 0.12 |
Antiplatelet drugs (%) | 18.8 | 16.8 | 0.63 | 17.0 | 28.5 | <0.0001 |
Tobacco smoking (%) | 14.4 | 13.7 | 0.84 | 14.2 | 14.6 | 0.83 |
Arterial hypertension (%) | 56.1 | 60.0 | 0.44 | 54.9 | 64.4 | 0.0002 |
Previous myocardial infarction (%) | 5.3 | 10.5 | 0.03 | 4.9 | 8.5 | 0.003 |